ArticleCancer drug resistance (Alhambra, Calif.)2021

Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma.

Jean-Marie Michot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.